LaunchBio: De-Risking Drug Development : Sep 17, 2020

LaunchBio: De-Risking Drug Development : Sep 17, 2020
/

Join experts from Cardinal Health Regulatory Sciences (CHRS) and the venture capital community in this discussion on regulatory due diligence. They will share the process of developing a “de-risking” framework, and provide insights throughout the regulatory lifecycle from discovery to early development and from clinical to post approval. Explore the processes that aid in decision-making related to product and portfolio development.

  • De-risking model for drug discovery & development
  • Assessing your technology readiness level (TRL)
  • Keys to conducting regulatory due diligence
  • Regulatory considerations for cell and gene therapy development

Registration – https://launchbio.org/feature/derisking-drug-development

From Sep 17, 2020 10:00AM to Sep 17, 2020 11:00AM at